Riskpilot← Back to searchSign inGet full accessSTORD AKUPUNKTURKLINIKK AS
ASActiveOrg 916939728Borggata 7, 5417 StordEconomic activity was not specified by tax authority · NACE 0000Est. 20160 employees
Revenue 2023
NOK 119K
EBITDA margin
1.0%
-76% vs 2022
Equity ratio
77.5%
Financial strength
Net profit 2023
NOK 743
-73% vs 2022
| Revenue | NOK 119K | — |
| EBITDA | NOK 1K | -76% |
| Net profit | NOK 743 | -73% |
| Total assets | NOK 33K | +33% |
| Equity | NOK 25K | +3% |
| Employees | 0 | — |
Legal name
STORD AKUPUNKTURKLINIKK AS
Org number
916939728
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
14. april 2016
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Klassisk akupunkturbehandling samt hva hermed står i forbindelse, herunder å delta i andre selskaper med tilsvarerende virksomhet.
Address
Borggata 7, 5417 Stord
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 119 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −0 | −8 | −2 | 5 | 1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −0 | −8 | −2 | 5 | 1 |
| Net financials | −0 | 0 | 0 | 0 | −0 |
| Profit before tax | −0 | −8 | −2 | 5 | 1 |
| Tax | −0 | −2 | −0 | 2 | 0 |
| Net profit | −0 | −6 | −1 | 3 | 1 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 30 | 28 | 27 | 25 | 33 |
| Equity | 30 | 23 | 22 | 25 | 25 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 5 | 5 | 0 | 7 |
| Total debt | 0 | 5 | 5 | 0 | 7 |
EBITDA margin
1.0%
This company
15.8%
Market median
-94% vs market
20192023
Equity ratio
77.5%
This company
38.2%
Market median
+103% vs market
20192023
Return on equity
2.9%
This company
18.4%
Market median
-84% vs market
20192023
Net profit margin
0.6%
This company
8.1%
Market median
-93% vs market
20192023
Asset turnover
3.64×
This company
1.12×
Market median
+225% vs market
20192023
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
BV Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Former (2) | ||
| Board of Directors | 2018 – 2018 | |
| Chairman | 2018 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Haugaland R1 As
STORD AKUPUNKTURKLINIKK AS Board members of STORD AKUPUNKTURKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bettina Veigner | Chief Executive Officer | 0 companies |
| Fredrik Balchen | Chairman | 0 companies |
| Karl-Henrik Lund Brinch | Board of Directors | 0 companies |
| Lars Johan Skeisvoll Hereid | Chairman | 0 companies |